Penumbra (PEN) Earnings Expected to Grow: What to Know Ahead of Next Week's ReleaseZacks Investment Research • 10/23/24
Penumbra, Inc. Announces Completion of THUNDER IDE Study Enrollment for Acute Ischemic StrokePRNewsWire • 10/14/24
Here's Why You Should Retain Penumbra Stock in Your Portfolio NowZacks Investment Research • 10/09/24
Penumbra, Inc. Schedules Third Quarter 2024 Earnings Release and Conference Call for October 30, 2024PRNewsWire • 10/02/24
PEN Stock to Gain From CE Mark Approval for its CAVT TechnologiesZacks Investment Research • 09/17/24
Penumbra Receives CE Mark for Computer Assisted Vacuum Thrombectomy Technologies - Lightning Flash™ 2.0 and Lightning Bolt™ 7 - in EuropePRNewsWire • 09/16/24
Penumbra: Growth In Its Thrombectomy Portfolio Should Lead To Strong EarningsSeeking Alpha • 08/20/24
Looking for a Growth Stock? 3 Reasons Why Penumbra (PEN) is a Solid ChoiceZacks Investment Research • 07/17/24
How Much Upside is Left in Penumbra (PEN)? Wall Street Analysts Think 34.22%Zacks Investment Research • 07/17/24
Penumbra, Inc. Schedules Second Quarter 2024 Earnings Release and Conference Call for July 30, 2024PRNewsWire • 07/02/24